Alzheimer's treatment Leqembi could cost Medicare up to $5 billion per year, study estimates

The authors said the estimated cost of Leqembi to Medicare are conservative, and spending on the Alzheimer's treatment may increase more than anticipated.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.